Filing Details
- Accession Number:
- 0001209191-15-074305
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-06 15:13:11
- Reporting Period:
- 2015-10-05
- Filing Date:
- 2015-10-06
- Accepted Time:
- 2015-10-06 15:13:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1527599 | Mirna Therapeutics Inc. | MIRN | Pharmaceutical Preparations (2834) | 261824804 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1544328 | New Enterprise Associates 14, L.p. | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-10-05 | 1,241,650 | $0.00 | 1,241,650 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2015-10-06 | 257,516 | $0.00 | 1,499,166 | No | 4 | J | Direct | |
Common Stock | Acquisiton | 2015-10-05 | 583,559 | $0.00 | 2,082,725 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2015-10-06 | 31,650 | $0.00 | 2,114,375 | No | 4 | J | Direct | |
Common Stock | Acquisiton | 2015-10-06 | 857,142 | $7.00 | 2,971,517 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | J | Direct | |
No | 4 | C | Direct | |
No | 4 | J | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Preferred Stock | Disposition | 2015-10-05 | 1,241,650 | $0.00 | 1,241,650 | $0.00 |
Common Stock | Series D Preferred Stock | Disposition | 2015-10-05 | 583,559 | $0.00 | 583,559 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Each share of Series C Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
- The securities are directly held by New Enterprise Associates 14, L.P. ("NEA 14") and are indirectly held by NEA Partners 14, L.P. ("NEA Partners 14"), the sole general partner of NEA 14, NEA 14 GP, LTD ("NEA 14 LTD"), the sole general partner of NEA Partners 14 and each of the individual directors of NEA 14 LTD (NEA Partners 14, NEA 14 LTD and the individual directors of NEA 14 LTD (collectively, the "Directors") together, the "Indirect Reporting Persons"). The Directors of NEA 14 LTD are M. James Barrett, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Krishna "Kittu" Kolluri, David M. Mott, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan and Harry R. Weller. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 securities in which the Indirect Reporting Persons have no pecuniary interest.
- The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series C Preferred Stock of the Company.
- Each share of Series D Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
- The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series D Preferred Stock of the Company.
- Due to a clerical error, the Reporting Person's Form 3 which previously reported the holding of these shares understated the total by one (1) share.
- The expiration date is not relevant to the conversion of these securities.